Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

byBenzinga Newsdesk

December 6, 2022

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

Cantor Fitzgerald Drops Coverage On These 3 Marijuana Stocks

By Nina Zdinjak

February 6, 11:01 AM

Cantor Fitzgerald’s Pablo Zaunic discontinued research coverage of Aleafia Health (OTCQB: ALEAF), Flora Growth (NASDAQ: FLGC) and Auxly Cannabis (OTCQB: CBWTF).&n

ALEAF

Why Revelation Biosciences Is Trading 40% Lower Thursday

By Henry Khederian

February 9, 2:54 PM

Revelation Biosciences Inc (NASDAQ: REVB) shares are trading lower by 41.98% Thursday afternoon. The company priced a 3.225 million share offering for gross proceeds of $15.6 million. What Else?

REVB

Analyst Ratings

The Latest Analyst Ratings for Weatherford International

By Benzinga Insights

May 1, 11:01 AM

Analysts have provided the following ratings for Weatherford International (NASDAQ:WFRD) within the last quarter: Bullish Somewhat Bullish Indifferent…

WFRD